argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
781.72
+5.70 (0.73%)
At close: Apr 30, 2026, 4:00 PM EDT
797.00
+15.28 (1.95%)
After-hours: Apr 30, 2026, 6:56 PM EDT
argenx SE Market Cap
argenx SE has a market cap or net worth of $48.73 billion as of April 30, 2026. Its market cap has increased by 32.27% in one year.
Market Cap
48.73B
Enterprise Value
44.35B
1-Year Change
32.27%
Ranking
Category
Stock Price
$781.72
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $48.73B, an increase of 7,785.87%. That is a compound annual growth rate of 62.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 48.02B | -6.44% |
| Dec 31, 2025 | 51.33B | 39.57% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 107.66B |
| Regeneron Pharmaceuticals | 69.88B |
| Alnylam Pharmaceuticals | 40.19B |
| BeOne Medicines AG | 32.32B |
| Revolution Medicines | 29.56B |
| Royalty Pharma | 29.34B |
| Insmed | 29.15B |
| BioNTech SE | 25.69B |